Fulgent Genetics Inc logo

Fulgent Genetics Inc

$ 38.12 -0.66 (-1.7%) 04:00 PM EST
P/E:
3.08
P/B:
0.90
Market Cap:
$ 1.17B
Enterprise V:
$ 679.10M
Volume:
194.03K
Avg Vol (2M):
337.38K
Also Trade In:
Volume:
194.03K
Market Cap $:
1.17B
PE Ratio:
3.08
Avg Vol (2-Month):
337.38K
Enterprise Value $:
679.10M
PB Ratio:
0.90
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Name Current Vs Industry Vs History
Cash-To-Debt 24.79
Equity-to-Asset 0.89
Debt-to-Equity 0.02
Debt-to-EBITDA 0.04
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.73
Distress
Grey
Safe
Beneish M-Score -2.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 199.9
3-Year Book Growth Rate 139
Name Current Vs Industry Vs History
5-Day RSI 39.37
9-Day RSI 31.92
14-Day RSI 31.48
6-1 Month Momentum % -31.13
12-1 Month Momentum % -50.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.29
Quick Ratio 5.2
Cash Ratio 4.04
Days Inventory 24.62
Days Sales Outstanding 55.38
Days Payable 36.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.4

Financials (Next Earnings Date:2022-11-09 Est.)

FLGT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FLGT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 925.148
EPS (TTM) ($) 12.57
Beta 1.72
Volatility % 50.33
14-Day RSI 31.48
14-Day ATR ($) 1.552558
20-Day SMA ($) 41.008
12-1 Month Momentum % -50.2
52-Week Range ($) 37.335 - 109.55
Shares Outstanding (Mil) 30.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fulgent Genetics Inc Filings

Document Form Filing Date
No Filing Data

Fulgent Genetics Inc Analysis

Share your research

Headlines

See More
No news.